Bellon Christine
Chief Legal Officer
Bellon Christine has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Apr 6, 2026.
On the most recent filing, Bellon Christine is listed as Chief Legal Officer at Beam Therapeutics Inc. Inside the rolling window, Bellon Christine reported no open-market purchases and 5 open-market sales totaling $881K in BEAM. The largest disclosed transaction in the window is a sale of 18,629 BEAM shares on Jan 15, 2026, worth $645K.
Companies traded
Other insiders at BEAM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$881K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bellon Christine made?
Bellon Christine has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Bellon Christine trade?
Bellon Christine has filed SEC Form 4 disclosures for 1 company, including BEAM.
When was Bellon Christine's most recent SEC Form 4 filing?
Bellon Christine's most recent SEC Form 4 filing on Tracefour is dated Apr 6, 2026.
What is Bellon Christine's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bellon Christine is listed as Chief Legal Officer.
What is Bellon Christine's total buy and sell value in the current window?
Inside the rolling retention window, Bellon Christine bought $0 and sold $881K based on SEC Form 4 filings.
What was Bellon Christine's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,629 BEAM shares on 2026-01-15, worth $645K, per SEC Form 4 filings.